Denikitug
Based on 1 Customer Validation
Denikitug (GS-1811; JTX-1811) is a humanized monoclonal antibody against CCR8 receptor with a KD of 16.8 pM. Denikitug specifically binds to human CCR8, inhibits CCL1-induced downstream CCR8 signaling. Denikitug selectively depletes cells expressing CCR8 via antibody-dependent cellular cytotoxicity (ADCC). Denikitug promotes anti-tumor immunity and can be used for the research of cancer and immunology.
For research use only. We do not sell to patients.
- Purity : 99.00%
- CAS No.: 2865822-82-6
- Molecular Weight:147.2 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
CCR8 16.8 pM (Kd) |
In Vitro
Denikitug exhibits high on-cell affinity for human CCR8, with an average KD of 16.8 pM[1].
Denikitug (0.0001-100 µg/mL) specifically binds to human CCR8-expressing CHO-S cells and does not bind to human CCR4-expressing or parental CHO-S cells[1].
Denikitug (0.001-100 µg/mL) potently antagonizes CCL1-induced signaling downstream of human CCR8[1].
Denikitug (10-4-100 µg/mL, overnight) mediates potent ADCC of cells expressing human CCR8, with an average EC50 of 0.0067 µg/mL[1].
Denikitug (10-6-1000 µg/mL, overnight) potently mediates ADCC of Hut78 cells endogenously expressing human CCR8 at tumor-infiltrating Treg levels, with an average EC50 of 0.0017 µg/mL and maximum killing of 67.5%[1].
Denikitug (1 µg/mL) mediates specific depletion of tumor-infiltrating Tregs ex vivo from human ovarian, lung, and colon tumors[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:CHO-S cells expressing 2500 copies of human CCR8 per cell, human NK cells isolated from healthy donors
-
Concentration:10-8-100 µg/mL
-
Incubation Time:overnight
-
Result:Exhibited potent ADCC activity, with an average EC50 of 0.0067 µg/mL (range: 0.00094-0.023 µg/mL) across 10 independent NK cell donors.
-
Cell Line:Hut78 cells (endogenously expressing human CCR8 at tumor-infiltrating Treg levels), human NK cells isolated from healthy donors
-
Concentration:10-6-1000 µg/mL
-
Incubation Time:overnight
-
Result:Had an average EC50 of 0.0017 µg/mL and an average maximum killing of 67.5% across three NK cell donors.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG1-kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Flow Cytometry analysis of Raji cells labelling CCR8 (red) with Denikitug (HY-P990914). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
CAS No. 2865822-82-6
-
Appearance Liquid
-
Molecular Weight 147.2 kDa
-
Color Colorless to light yellow
-
SMILES
[Denikitug]
-
Synonyms
GS-1811; JTX-1811
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (261 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)